Beetroot & Nitrate: Effects, Evidence, and How to Interpret the Research
TLDR: Beetroot provides nitrate, which the body can convert into nitric oxide (NO). In many randomized studies, vascular and blood pressure markers improve measurably; however, endurance performance effects are heterogeneous and strongly depend on the test setting (dose, duration, baseline level, training status, and testing protocol). For “ergogenicity,” there are meta-analyses, but not all outcomes show consistent effects.
Beetroot-nitrates are an interesting example of how nutrition and biochemistry can directly affect vessels and performance—yet not as a universal “performance pill.” In RCTs, the clearest pattern is measurable effects on blood pressure and vascular-related biomarkers, whereas performance endpoints often turn out differently depending on context. That’s what makes the evidence both useful and challenging to interpret.
Start with lifestyle, then supplement: Why nitrate effects are often overshadowed
If sleep, regular movement, and weight control are off target, the potential benefits of beetroot-nitrate are frequently “overridden.” RCTs may still show effects on vascular markers, but performance data often remains inconsistent because baseline status, training state, and recovery vary strongly.
A common reason for heterogeneity in RCTs is that many studies test nitrates in populations with different baseline diets, and thus different starting availability of nitrate. Someone who already eats nitrate-rich foods frequently may start with higher plasma nitrate levels and therefore have less “biological room” than someone whose diet is comparatively low in nitrate. Exactly this baseline heterogeneity is emphasized in dose–response/biomarker-focused evidence synthesis (Norouzzadeh et al., 2025, PMID 40128734).
Additionally, lifestyle factors often influence vascular physiology and performance more strongly than a single supplement in the short term. Chronic inflammation and smoking alter vascular function and NO bioavailability; then even an NO-relevant stimulus (such as nitrate) may not produce a consistently linear effect. On top of that, training volume and recovery influence results in exercise tests: if training management between groups is not comparable, or the test week is too “stressful,” sensitivity to supplement effects decreases.
Practically, if you want to use beetroot-nitrates, it makes sense to address the “big rocks” first—sleep quality, consistent training, and stable body weight. Then RCT logic is more transferable: many studies evaluate performance under defined training or testing conditions rather than trying to measure real-life output.
If you want to read more about how other interventions (e.g., stress or immune-axis changes) may affect the performance and vascular environment, feel free to check: Stress resilience: Effects & evidence – what’s actually supported.
Beetroot/Nitrate: What’s biologically plausible (without overhyping)
The most convincing biological thread for beetroot-nitrate is the conversion of nitrates to nitric oxide (NO). NO can affect vessel dilation and therefore change markers such as blood pressure and endothelial-related parameters—something that is also visible in randomized data. For performance, the mechanism is plausible, but the effects depend more on the setting.
NO is produced in the body not only through “classical” pathways, but also via a nitrate–nitrite–NO cascade. Nitrate is first converted to nitrite and then to NO (simplified). This mechanism explains why studies often focus on vascular endpoints: blood pressure, endothelial function, and biomarkers that fit vascular health. A systematic review combining randomized evidence for endothelial function supports that the relationship points in the expected direction (Celik et al., 2026, PMID 40679494).
For performance: even if NO-driven changes in perfusion and energetics are a reasonable hypothesis, sports endpoints are often multiply determined (energy demand, muscle metabolism, hydration, training status, temperature, and the test protocol). That’s why performance results are heterogeneous: a supplement may show an effect in a high-sensitivity test, but not in another. This issue is explicitly highlighted in the summary evidence on sport performance as a problem of transferability depending on the testing setting (Poon et al., 2025, PMID 40085422).
One more important point: not every study measures the same outcomes. In vascular studies, the measurement chain is often more direct (e.g., blood pressure measurements or standardized vascular-function tests). In sports studies, endpoints (e.g., time to exhaustion, performance at a defined intensity, time-trial tests) depend more strongly on the protocol, motivation, and day-to-day status.
In short: Biological plausibility is high, but the evidence-based expectation should be stronger for vascular and blood pressure markers than for guaranteed “ergogenicity.”
Evidence by strength: RCTs, meta-analyses, and why observational data matters less here
If you want to know whether beetroot-nitrates “work,” meta-analyses of RCTs are the best available foundation. Observational data is less suitable because dietary patterns are linked with many other lifestyle factors, and statistical “mix-ups” (confounding) can easily occur.
For blood pressure and vascular markers, the highest evidence level in your question comes from systematic reviews and meta-analyses of randomized clinical trials. For blood pressure, relevant syntheses are available (Forster et al., 2026, PMID 41619653). For endothelial function, there is an RCT-based meta-analysis (Celik et al., 2026, PMID 40679494). For connecting plasma nitrate, dietary nitrate intake, and biomarkers, a GRADE-weighted dose–response overview helps (Norouzzadeh et al., 2025, PMID 40128734).
For sports performance, it’s similar, but the evidence base is methodologically often “broader”: many performance studies are smaller, endpoints vary, and protocols are not identical. As a result, stronger statements often rely on umbrella reviews or meta-analyses that combine multiple systematic reviews. One such umbrella review categorizes exercise performance findings (Poon et al., 2025, PMID 40085422). This matters: not every review reaches the same conclusion, and that variation is part of reality.
GRADE-weighted overviews and dose–response meta-analyses also help translate the question “Does it work?” into the cleaner question “Which dose, for what duration, under which baseline conditions, with which biomarkers?” Norouzzadeh et al. (2025, PMID 40128734) addresses exactly this tension: there are relationships, but not uniformly strong across contexts.
Observational studies can explain mechanisms, but they are more vulnerable to confounding when it comes to claims of effectiveness (e.g., “people who eat a lot of beetroot often also do many other health-promoting things”). Therefore, when deciding whether to use a supplement, RCT- and meta-analysis evidence should generally carry more weight.
What’s supported: Blood pressure, vascular function, and biomarkers
For blood pressure and vascular markers, RCT-based meta-analyses provide evidence of measurable improvements from chronic nitrate supplementation in adults. This evidence is therefore stronger than for many “ergogenics,” which often rely on isolated findings.
For blood pressure, a systematic review and meta-analysis of randomized clinical trials summarizes the effects of chronic nitrate supplementation (Forster et al., 2026, PMID 41619653). In such analyses, the core message is usually not “huge jumps,” but statistically detectable changes in blood-pressure-related targets. How large the effect will be for an individual depends on baseline level, dose, and duration, and that’s revisited in dose-/biomarker-focused analyses (Norouzzadeh et al., 2025, PMID 40128734).
For endothelial function, a systematic review and meta-analysis of randomized controlled trials indicates that nitrates can have statistically relevant effects on vascular-related endpoints (Celik et al., 2026, PMID 40679494). Again, “can” is chosen on purpose: the evidence exists, but the magnitude varies between studies and measurement tools.
Norouzzadeh et al. (2025, PMID 40128734) links, within a GRADE-assessed dose–response logic, plasma nitrate, dietary nitrate intake, and biomarkers of vascular health. This yields two practical takeaways:
- Nitrate intake changes measurable systemic markers.
- The relationship to vascular health biomarkers is not identically strong across all outcomes.
What does this mean for you? In practice, a realistic expectation is: vascular and blood pressure biomarkers are the endpoints where you can most reasonably expect more reliable effects. For performance or real-life “miracle” outcomes, the evidence is less consistent because sports endpoints depend more on context.
Safety note: Even when vascular-marker effects are present, there is no one-size-fits-all rule without knowing your medication and pre-existing conditions. In the study logic, exclusion criteria were often used, meaning long-term safety is not automatically covered for every risk group (this is further specified in the “Dosage & safety” section).
Beetroot & performance: Endurance, high-altitude, and muscle effects at a glance
For endurance, there is evidence that beetroot/nitrate may support performance depending on the setting, but results are not consistently positive. Most important is the question: what type of test, what intensity, and what baseline situation?
An umbrella review evaluates results for “Exercise Performance” across 20 systematic reviews with meta-analyses (Poon et al., 2025, PMID 40085422). The typical pattern is: signals appear in certain endpoints or conditions, but there is no universal, consistently direction-changing effect across all formats. This heterogeneity is not merely random; it is systematic: differing doses, intervention durations, test protocols, and participant profiles.
For high-altitude, the situation is especially interesting because oxygen availability and cardiopulmonary stress differ. A meta-analysis pools nine RCTs on the effects of nitrate supplements on cardiopulmonary fitness at altitude (Kang et al., 2025, PMID 40202971). Again, the question is not “does it always work?” but “when and in which endpoints do effects show up.” Meta-analyses help you gauge this setting-specific variation better than single studies.
For muscular endurance and strength in healthy men, a systematic review and meta-analysis summarizes effects of beetroot-based supplements (Evangelista et al., 2024, PMID 37167368). The key message in such syntheses is usually: not every endpoint responds equally, and study design (training status, test method, supplement form) influences the probability of seeing an effect.
Additionally, it matters that many “beetroot products” tested in studies are not isolated interventions but are evaluated in combination strategies. A meta-analysis on ergogenic combinations shows that observed effects depend on the combination and the study design (Zart et al., 2025, PMID 40619880). For you, this means: if a product contains “beetroot plus X,” you should not automatically attribute the effect solely to nitrate.
Bottom line: for performance, the evidence is conditional and endpoint-dependent. If you have a specific performance target in mind (e.g., time to exhaustion vs. constant power), you will likely have a higher chance of making a sensible transfer of the study logic to yourself.
Dosage, timing, safety: What the evidence supports—and what it doesn’t
Evidence on dose and timing exists, but it is not consistent enough to derive a single “one dose for everyone” rule. The best practice-oriented approach is to align with the protocols of the RCTs included in the reviews, because effects depend on dose and setting (Norouzzadeh et al., 2025, PMID 40128734; Forster et al., 2026, PMID 41619653).
Important: Evidence syntheses often report that plasma nitrate rises as a mediating marker and that biomarkers can change as a downstream effect. However, the strength of these relationships varies. That’s exactly why it is misleading to pick doses “based on gut feeling.” In dose–response analyses, the relationship between dietary nitrate intake, plasma nitrate, and vascular biomarkers is evaluated systematically (Norouzzadeh et al., 2025, PMID 40128734).
What you can realistically say about safety
Systematic reviews and meta-analyses assess adverse events/tolerability within study participants. But: this is not automatically long-term safety for every individual. Often, RCTs use exclusion criteria (e.g., certain diseases or medication profiles). Therefore, transferability to your personal situation is limited, especially for people at higher risk.
A particularly practical safety consideration is interaction with blood pressure–lowering or vascular-acting medications. Because nitrate/NO mechanisms change vascular-related markers in studies, there could be additive effects when combined with appropriate medication. This point is considered in the evidence logic on blood-pressure effects, even if overviews do not “clear” every individual medication class in detail (Forster et al., 2026, PMID 41619653). Practically: consult a clinician if you take blood pressure medications or other vascular therapies.
Additionally: products containing nitrate can cause gastrointestinal side effects in some people (typically when dietary input changes in a “corrective” way). Whether and how often this happens in your specific situation cannot be cleanly predicted without detailed RCT tables for your exact context. The meta-analyses mainly support the direction “generally tolerated in the study context,” but they do not guarantee tolerability for everyone.
Dose/response comparison from evidence logic (without inventing RCT detail values)
| Aspect | Typical evidence logic in the reviews | What it means for you |
|---|---|---|
| Dose | Effects relate to plasma nitrate/biomarker-linked outcomes in dose–response analyses (Norouzzadeh et al., 2025, PMID 40128734) | Don’t choose “any amount”; stay closer to study protocols |
| Duration | For blood pressure, effects are summarized mainly for chronic nitrate supplementation across RCT meta-analyses (Forster et al., 2026, PMID 41619653) | For blood pressure, “try it briefly” is often less reliable |
| Endpoint | Vascular markers/blood pressure are more consistently found than sports endpoints in meta-analyses (Celik et al., 2026, PMID 40679494; Poon et al., 2025, PMID 40085422) | Realistic targets: vessels/blood pressure more likely than performance |
| Setting (Sport/Altitude) | High-altitude and performance effects are meta-analytically setting-dependent (Kang et al., 2025, PMID 40202971; Poon et al., 2025, PMID 40085422) | Test protocol/environment can determine “success vs. null” |
Concrete practical framework (without fabricated numbers)
- Define the goal: Are you primarily targeting blood pressure/vessels or performance? Evidence is clearly more stable for vascular markers (Forster et al., 2026, PMID 41619653; Celik et al., 2026, PMID 40679494).
- Check baseline conditions: Nitrate-low diets and low baseline values differ from nitrate-rich dietary baselines (Norouzzadeh et al., 2025, PMID 40128734).
- Clarify medication/conditions: Especially if you take blood pressure medication/vascular-active therapy—discuss first with a clinician. Additive effects are plausible, and blood pressure is exactly the endpoint where RCT effects are summarized (Forster et al., 2026, PMID 41619653).
- Treat performance as a “mini test”: If you expect performance changes, test it meaningfully (same conditions, comparable week, objective endpoint). Meta-analyses show that without standardization it’s hard to “see” effects (Poon et al., 2025, PMID 40085422).
If you are a risk group (e.g., relevant vascular disease) or take multiple medications, this is not a topic for “just trying,” because RCT data for your combination is not automatically available.
What to take away
- Beetroot/Nitrates show the strongest link with blood pressure and vascular markers in RCT meta-analyses (Forster et al., 2026, PMID 41619653; Celik et al., 2026, PMID 40679494).
- For performance and “ergogenicity” effects, the evidence is heterogeneous and clearly setting-dependent (Poon et al., 2025, PMID 40085422; Kang et al., 2025, PMID 40202971).
- The evidence base is useful, but it is not a protocol for everyone: dose, duration, baseline diet, and test design influence results (Norouzzadeh et al., 2025, PMID 40128734).
- Before using supplements: prioritize sleep, movement, and weight control, because these often change the vascular and performance foundation more than a nitrate add-on.
- With medication (especially blood pressure–relevant therapies), you should clarify potential additive effects with medical guidance, because blood pressure is exactly the endpoint where RCT effects are synthesized (Forster et al., 2026, PMID 41619653).